東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Behavioral neurobiology of psychedel...

Vollenweider, Franz X.

FindBook

Google Book

Amazon

博客來

Behavioral neurobiology of psychedelic drugs

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Behavioral neurobiology of psychedelic drugs/ edited by Franz X. Vollenweider, David E. Nichols.
其他作者:	Vollenweider, Franz X.
出版者:	Berlin, Heidelberg :Springer Berlin Heidelberg : : 2018.,
面頁冊數:	x, 430 p. :ill. (some col.), digital ;24 cm.
內容註:	Preface -- Chemistry and structure-activity relationships of psychedelics -- Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways -- Effects of hallucinogens on neuronal activity -- Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons -- The effects of hallucinogens on gene expression -- Effect of Hallucinogens on Unconditioned Behavior -- Hallucinogens in Drug Discrimination -- Phenomenology, structure and dynamic of psychedelic states -- Serotonergic hallucinogen-induced visual perceptual alterations -- New world tryptamine hallucinogens and the neuroscience of ayahuasca -- Experimental psychosis research and schizophrenia - similarities and dissimilarities in psychopathology -- A review of Hallucinogen Persisting Perception Disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD -- Therapeutic applications of classic hallucinogens -- Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.
Contained By:	Springer eBooks
標題:	Hallucinogenic drugs. -
電子資源:	http://dx.doi.org/10.1007/978-3-662-55880-5
ISBN:	9783662558805

Behavioral neurobiology of psychedelic drugs
Behavioral neurobiology of psychedelic drugs[electronic resource] /edited by Franz X. Vollenweider, David E. Nichols. - Berlin, Heidelberg :Springer Berlin Heidelberg :2018. - x, 430 p. :ill. (some col.), digital ;24 cm. - Understanding complex systems,v.361866-3370 ;. - Understanding complex systems ;v.36..

Preface -- Chemistry and structure-activity relationships of psychedelics -- Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways -- Effects of hallucinogens on neuronal activity -- Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons -- The effects of hallucinogens on gene expression -- Effect of Hallucinogens on Unconditioned Behavior -- Hallucinogens in Drug Discrimination -- Phenomenology, structure and dynamic of psychedelic states -- Serotonergic hallucinogen-induced visual perceptual alterations -- New world tryptamine hallucinogens and the neuroscience of ayahuasca -- Experimental psychosis research and schizophrenia - similarities and dissimilarities in psychopathology -- A review of Hallucinogen Persisting Perception Disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD -- Therapeutic applications of classic hallucinogens -- Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action. Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.

ISBN: 9783662558805

Standard No.: 10.1007/978-3-662-55880-5doiSubjects--Topical Terms:

770603
Hallucinogenic drugs.

LC Class. No.: RM324.8 / .B443 2018

Dewey Class. No.: 615.7883

Behavioral neurobiology of psychedelic drugs
LDR:02928nmm a2200325 a 4500 001 2136432
003 DE-He213
005 20180831132545.0
006 m d
007 cr nn 008maaau
008 181117s2018 gw s 0 eng d
020 $a 9783662558805 $q (electronic bk.)
020 $a 9783662558782 $q (paper)
024 7 $a 10.1007/978-3-662-55880-5 $2 doi
035 $a 978-3-662-55880-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RM324.8 $b .B443 2018
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 615.7883 $2 23
090 $a RM324.8 $b .B419 2018
245 0 0 $a Behavioral neurobiology of psychedelic drugs $h [electronic resource] / $c edited by Franz X. Vollenweider, David E. Nichols.
260 $a Berlin, Heidelberg : $b Springer Berlin Heidelberg : $b Imprint: Springer, $c 2018.
300 $a x, 430 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Understanding complex systems, $x 1866-3370 ; $v v.36
505 0 $a Preface -- Chemistry and structure-activity relationships of psychedelics -- Hallucinogens and serotonin 5-HT2A receptor-mediated signaling pathways -- Effects of hallucinogens on neuronal activity -- Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons -- The effects of hallucinogens on gene expression -- Effect of Hallucinogens on Unconditioned Behavior -- Hallucinogens in Drug Discrimination -- Phenomenology, structure and dynamic of psychedelic states -- Serotonergic hallucinogen-induced visual perceptual alterations -- New world tryptamine hallucinogens and the neuroscience of ayahuasca -- Experimental psychosis research and schizophrenia - similarities and dissimilarities in psychopathology -- A review of Hallucinogen Persisting Perception Disorder (HPPD) and an exploratory study of subjects claiming symptoms of HPPD -- Therapeutic applications of classic hallucinogens -- Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.
520 $a This volume brings together the latest basic and clinical research examining the effects and underlying mechanisms of psychedelic drugs. Examples of drugs within this group include LSD, psilocybin, and mescaline. Despite their structural differences, these compounds produce remarkably similar experiences in humans and share a common mechanism of action. Commonalities among the substances in this family are addressed both at the clinical and phenomenological level and at the basic neurobiological mechanism level. To the extent possible, contributions relate the clinical and preclinical findings to one another across species. The volume addresses both the risks associated with the use of these drugs and the potential medical benefits that might be associated with these and related compounds.
650 0 $a Hallucinogenic drugs. $3 770603
650 0 $a Neurobiology. $3 588707
650 0 $a Clinical neuropsychology. $3 564479
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Neurosciences. $3 588700
650 2 4 $a Psychopharmacology. $3 568143
650 2 4 $a Medicinal Chemistry. $3 892420
700 1 $a Vollenweider, Franz X. $3 3307807
700 1 $a Nichols, David E. $3 3307808
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Understanding complex systems ; $v v.36. $3 3307809
856 4 0 $u http://dx.doi.org/10.1007/978-3-662-55880-5
950 $a Biomedical and Life Sciences (Springer-11642)